4 years ago Tags General Interest Reopening EU: Too Soon? As countries in the European Union undertake measures to open the bloc for non-essential travel, they will have to strictly…
4 years ago Tags General Interest A Cure For Alzheimer’s? The authorisation of Aducanumab, a new drug to cure Alzheimer’s, by the U.S. Food & Drug Administration has generated debates…
4 years ago Tags General Interest Olympics in the Shadow of Covid-19 Japan is experiencing its fourth wave of the coronavirus pandemic. However, there have been no talks of cancelling or postponing
4 years ago Tags General Interest Fourth Estate Under Siege Reporters across the globe are witnessing an increase in threats, arrests, and censorship.
4 years ago Tags General Interest Shrinking Labour Pool With declining demographic growth rates, China will have to restructure its manpower- intensive economy.
4 years ago Tags General Interest India’s AstraZeneca Deal The global controversy surrounding AstraZeneca, India’s primary vaccine, together with an inadequate adverse reaction reporting system, has given rise to…
4 years ago Tags General Interest Getting the Online, in Line In a market as large and diverse as India, it is important to tailor regulatory requirements with great care if…
4 years ago Tags General Interest Believing the Written Word Though social media reach is tremendous in India, its platforms have not been used to spread misinformation or create agitations.
4 years ago Tags General Interest Fighting Misinformation The way forward is to have governments and institutions working together for a disinformation-free society
4 years ago Tags General Interest Nixing Fake News The only way to nip misinformation in the bud is to work alongside social media platforms.